For individuals with diabetes mellitus, HbA1 C serves as a therapeutic target for adjusting glucose-lowering treatments, as it shows a significant correlation with the risk of developing microvascular complications related to diabetes mellitus [5]. This evidence concerns the gene HBA1 and diabetes mellitus.